Aventis Arava Liver Toxicity Warning Is Satisfactory, FDA Arthritis Cmte. Says

Aventis' existing labeled warnings for Arava regarding liver toxicity do not need to be strenghened, members of FDA's Arthritis Advisory Committee told the agency at its March 5 safety review of the arthritis drug